Novartis India Shows Profit Growth Amidst Flat Overall Financial Performance

Novartis India has recently undergone a financial trend adjustment, reflecting a flat performance for the quarter ending September 2025. The company's score has seen a notable decline over the past three months, indicating a shift in its financial standing.
Despite this adjustment, certain metrics highlight positive aspects of Novartis India's operations. The company's profit after tax (PAT) for the first nine months stands at Rs 81.14 crore, showcasing a growth rate of 33.39%. Additionally, profit before tax (PBT) excluding other income for the quarter is reported at Rs 23.25 crore, with a growth of 34.86%. These figures suggest that while the overall financial trend may be flat, the company is managing to achieve significant growth in key profitability metrics.

In terms of market performance, Novartis India has faced challenges compared to the Sensex. Over the past year, the stock has declined by 16.97%, while the Sensex has gained 5.78%. This trend is further emphasized in the longer-term view, where Novartis India has underperformed against the Sensex across various time frames, including a 6.12% decline year-to-date.

Overall, while Novartis India demonstrates strong growth in specific financial metrics, its stock performance relative to the broader market indicates areas that may require strategic focus moving forward.